Stock Research: M1 Kliniken

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

M1 Kliniken

XTRA:M12 DE000A0STSQ8
96
  • Value
    98
  • Growth
    37
  • Safety
    Safety
    73
  • Combined
    88
  • Sentiment
    95
  • 360° View
    360° View
    96
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

M1 Kliniken AG operates medical centers for aesthetic and plastic treatments, offering services like wrinkle and breast corrections, liposuction, and face lifts. It is primarily in the healthcare and aesthetic medicine industry, with medical centers in Germany (Berlin, Essen, Dusseldorf, Cologne, Munich). In the last fiscal year, the company had a market cap of $331 million, profits of $66 million, revenue of $351 million, and 152 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 96 (better than 96% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock M1 Kliniken are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for M1 Kliniken. The consolidated Value Rank has an attractive rank of 73, which means that the share price of M1 Kliniken is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 73% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 98. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 95. But the consolidated Growth Rank has a low rank of 37, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 63 of its competitors have better growth. ...read more

more
Index
CDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
73 66 70 77
Growth
37 60 91 61
Safety
Safety
98 100 96 90
Sentiment
95 92 100 87
360° View
360° View
96 100 100 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 95 97 71
Opinions Change
87 50 89 50
Pro Holdings
n/a 100 78 92
Market Pulse
30 51 55 30
Sentiment
95 92 100 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
73 66 70 77
Growth
37 60 91 61
Safety Safety
98 100 96 90
Combined
88 96 100 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
76 59 45 88
Price vs. Earnings (P/E)
69 69 69 95
Price vs. Book (P/B)
46 46 64 97
Dividend Yield
94 96 96 1
Value
73 66 70 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
56 64 76 69
Profit Growth
37 76 96 34
Capital Growth
66 6 41 79
Stock Returns
31 80 77 21
Growth
37 60 91 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
85 86 80 72
Refinancing
74 75 83 95
Liquidity
84 83 68 39
Safety Safety
98 100 96 90

Similar Stocks

Discover high‑ranked alternatives to M1 Kliniken and broaden your portfolio horizons.

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.